Skip to main content

Constipation in Cancer Patients

  • Chapter
  • First Online:

Abstract

The prevalence of constipation varies widely due to non-reporting or because this information is not captured during visits to hospital or outpatient clinics; however, it has been estimated to be in a range of 0.7 % to 79 % (median 16 %) in the worldwide general population (Mugie et al. Best Pract Res Clin Gastroenterol 25(1):3–18, 2011). Mugie and colleagues state that the difference can be attributed to other factors including socioeconomic, cultural, dietary, and environmental. There have been challenges to the way we practice medicine as a result of healthcare reform occurring in the United States and worldwide. Patients’ involvement in their care, and preventive care, is widely emphasized, as well as conscious use of limited resources. Visits to the emergency department (ED) and hospital admissions for constipation are considered avoidable if recognition of the risk factors and education are initiated proactively (Delgado-Guay et al. J Pain Symptom Manage 49(3):497–504, 2015).

Constipation is a common complaint in the ED. In this chapter, we will evaluate and discuss the factors associated with constipation in cancer patients, together with clinical manifestations, diagnoses, mechanism, and pathophysiology. We will also discuss when constipation constitutes an emergency, its treatment, prevention, and patient education.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Mugie SM, Benninga MA, DiLorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011;25(1):3–18.

    Article  PubMed  Google Scholar 

  2. Delgado-Guay MO, Kim YJ, Shin SH, Chisholm G, Williams J, Allo J, et al. Avoidable and unavoidable visits to the emergency department among patients with advanced cancer receiving outpatient palliative care. J Pain Symptom Manage. 2015;49(3):497–504.

    Article  PubMed  Google Scholar 

  3. Gu M, Gonzalez C, Todd K. Emergent management of constipation in cancer patients. Emerg Med. 2011;43(11):6–12.

    Google Scholar 

  4. Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;349(14):1360–8.

    Article  CAS  PubMed  Google Scholar 

  5. Chevalier P, Lamotte M, Joseph A, Dubois D, Boeckxstaens G. In-hospital costs associated with chronic constipation in Belgium: a retrospective database study. Neurogastroenterol Motil. 2014;26(3):368–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ansari H, Ansari Z, Hutson JM, Southwell BR. Potentially avoidable hospitalisation for constipation in Victoria, Australia in 2010-11. BMC Gastroenterol. 2014;14:125.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377–90.

    Article  PubMed  Google Scholar 

  8. Sharma RK. Vincristine and gastrointestinal transit. Gastroenterology. 1988;95(5):1435–6.

    CAS  PubMed  Google Scholar 

  9. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999;341(21):1565–71.

    Article  CAS  PubMed  Google Scholar 

  10. Robinson BG, Paz-Ares L, Krebs A, Vasselli J, Haddad R. Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Endocrinol Metab. 2010;95(6):2664–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. O’Connor O, Masszi T, Savage K. Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): results from the BELIEF trial. J Clin Oncol. 2013;31(15s):8507.

    Google Scholar 

  12. Clemens KE, Klaschik E. Management of constipation in palliative care patients. Curr Opin Support Palliat Care. 2008;2(1):22–7.

    Google Scholar 

  13. Librach SL, Bouvette M, De Angelis C, Farley J, Oneschuk D, Pereira JL, et al. Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage. 2010;40(5):761–73.

    Article  PubMed  Google Scholar 

  14. Neis B, Nguyen D, Arora A, Kane S. The role of diagnostic colonoscopy in constipation: a quality improvement project. Am J Gastroenterol. 2013;108(12):1930.

    Article  PubMed  Google Scholar 

  15. Clemens KE, Klaschik E. Management of constipation in palliative care patients. Curr Opin Support Palliat Care. 2008;2(1):22–7.

    Article  PubMed  Google Scholar 

  16. Sharma M, Agrawal A. Case report: Stercoral sigmoid colonic perforation with fecal peritonitis. Indian J Radiol Imaging. 2010;20(2):126–8.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Niv G, Grinberg T, Dickman R, Wasserberg N, Niv Y. Perforation and mortality after cleansing enema for acute constipation are not rare but are preventable. Int J Gen Med. 2013;6:323–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Robson P. Metastatic spinal cord compression: a rare but important complication of cancer. Clin Med. 2014;14(5):542–5.

    Article  Google Scholar 

  19. Wallaker K, Fortuna E, Bradin S, Macy M, Hassan M, Stanley R. Milk and molasses enemas: clearing things up. J Emerg Nurs. 2014;40(6):546–51.

    Article  PubMed  Google Scholar 

  20. Lacy BE, Hussain ZH, Mearin F. Treatment for constipation: new and old pharmacological strategies. Neurogastroenterol Motil. 2014;26(6):749–63.

    Article  CAS  PubMed  Google Scholar 

  21. Wirz S, Nadstawek J, Elsen C, Junker U, Wartenberg HC. Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose. Eur J Cancer Care (Engl). 2012;21(1):131–40.

    Article  CAS  Google Scholar 

  22. Sawh SB, Selvaraj IP, Danga A, Cotton AL, Moss J, Patel PB. Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients. Mayo Clin Proc. 2012;87(3):255–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Mackey AC, Green L, Greene P, Avigan M. Methylnaltrexone and gastrointestinal perforation. J Pain Symptom Manage. 2010;40(1):e1–3.

    Article  PubMed  Google Scholar 

  24. Mollaoğlu M, Erdoğan G. Effect on symptom control of structured information given to patients receiving chemotherapy. Eur J Oncol Nurs. 2014;18(1):78–84.

    Article  PubMed  Google Scholar 

  25. Izumi K. The measures to evaluate constipation: a review article. Gastroenterol Nurs. 2014;37(2):137–46.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmen Esther Gonzalez MD, CMQ, FACP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gonzalez, C.E., Halm, J.K. (2016). Constipation in Cancer Patients. In: Todd, K., Thomas, Jr., C. (eds) Oncologic Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-26387-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26387-8_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26385-4

  • Online ISBN: 978-3-319-26387-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics